Blastic phase of chronic myelogenous leukemia

  title={Blastic phase of chronic myelogenous leukemia},
  author={Merat Karbasian Esfahani and E. L. Morris and J. Dutcher and P. Wiernik},
  journal={Current Treatment Options in Oncology},
  • Merat Karbasian Esfahani, E. L. Morris, +1 author P. Wiernik
  • Published 2006
  • Medicine
  • Current Treatment Options in Oncology
  • Opinion statementChronic myelogenous leukemia (CML), also known as chronic myelocytic or chronic myeloid leukemia, is a clonal disorder of hematopoiesis that arises in a hematopoietic stem cell or early progenitor cell. This is characterized by the dysregulated production of mature non-lymphoid cells with normal differentiation. Eventually, in spite of the term chronic, there is progression to acute leukemia, usually of the myeloid variety, which is highly resistant to current therapies… CONTINUE READING
    40 Citations
    CML with Megakaryocytic Blast Crisis: Report of 3 Cases
    Monocytic crisis of chronic myeloid leukemia in the era of tyrosine kinase inhibitor.
    • 4
    • PDF
    Chronic Myeloid Leukemia with Extramedullary Blast Crisis: Two Unusual Sites with Review of Literature
    • 20


    Accelerated and blastic phase of chronic myeloid leukemia
    • 11
    Chronic Myelogenous Leukemia: Biology and Therapy
    • 330
    Pathobiology of lymphoid and myeloid blast crisis and management issues.
    • R. Ilaria
    • Medicine
    • Hematology. American Society of Hematology. Education Program
    • 2005
    • 44
    • PDF
    Blastic phase of chronic myelogenous leukemia.
    • 1
    Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.
    • 280
    The biology of CML blast crisis.
    • 572
    • PDF
    Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies
    • 71